Furthermore, AVIDa-hIL6 contains information on the interaction of diverse antibodies with 30 different mutants produced by artificial point mutations, in addition to the wild-type IL-6 protein. This ...

KYOTO, Japan--(BUSINESS WIRE)--A joint research paper on artificial intelligence (AI)-driven drug discovery by “SAKURA internet Research Center,” an in-house research institute of SAKURA internet Inc.

SEATTLE, May 16, 2023 — A-Alpha Bio, a synthetic biology and machine learning company that measures and engineers protein-protein interactions, and Lawrence Livermore National Laboratory (LLNL) today ...

Researchers have developed a novel antibody-based enzyme switch that converts antibody–antigen binding into enzyme activity, paving the way from detection via bioluminescence to the control of ...

Scientists from the US have recently characterized a panel of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies to identify molecular features of public antibody responses ...

As a basic description, an antibody can be described as any molecule that has epitopes (antigenic sites) that fit with corresponding antibodies, initiating an immune response. Antigens come in many ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies represent the fastest growing class of drugs in the market today, with over 60 antibody drugs currently approved for use and more than 550 in clinical development 1. They are highly ...